4.8 Review

LAG3's Enigmatic Mechanism of Action

Journal

FRONTIERS IN IMMUNOLOGY
Volume 11, Issue -, Pages -

Publisher

FRONTIERS MEDIA SA
DOI: 10.3389/fimmu.2020.615317

Keywords

LAG3; immune checkpoint; immune exhaustion; checkpoint inhibition; mechanism of action; Lymphocyte activation gene-3; immune checkpoint inhibitors

Categories

Funding

  1. Canadian Institutes of Health Research (CIHR) [HB2 - 164064]
  2. CIHR operating grant [PJT-148677]
  3. CIHR
  4. Research Manitoba

Ask authors/readers for more resources

This review outlines the importance of LAG3 as an immune checkpoint in cancer, infectious diseases, and autoimmunity, while also highlighting the gaps in understanding its biology, regulation, and mechanisms of action. Further research is needed to fully elucidate the role of LAG3 in disease and explore its potential as a target for therapeutic interventions.
LAG3 is an important immune checkpoint with relevance in cancer, infectious disease and autoimmunity. However, despite LAG3's role in immune exhaustion and the great potential of LAG3 inhibition as treatment, much remains unknown about its biology, particularly its mechanism of action. This review describes the knowns, unknowns and controversies surrounding LAG3. This includes examination of how LAG3 is regulated transcriptionally and post-translationally by endocytosis and proteolytic cleavage. We also discuss the interactions of LAG3 with its ligands and the purpose thereof. Finally, we review LAG3's mechanism of action, including the roles of LAG3 intracellular motifs and the lack of a role for CD4 competition. Overall, understanding the biology of LAG3 can provide greater insight on LAG3 function, which may broaden the appreciation for LAG3's role in disease and potentially aid in the development of targeted therapies.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.8
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available